Singapore - English - HSA (Health Sciences Authority)

abbvie pte. ltd. - lopinavir; ritonavir - tablet, film coated - 100mg - lopinavir 100mg; ritonavir 25mg

Singapore - English - HSA (Health Sciences Authority)

abbvie pte. ltd. - lopinavir; ritonavir - syrup - 80 mg - lopinavir 80 mg; ritonavir 20 mg

New Zealand - English - Medsafe (Medicines Safety Authority)

abbvie limited - lopinavir 80 mg/ml; ritonavir 20 mg/ml ((pharmacokinetic enhancer)) - oral solution - active: lopinavir 80 mg/ml ritonavir 20 mg/ml ((pharmacokinetic enhancer)) excipient: acesulfame potassium ammonium glycyrrhizinate castor oil citric acid ethanol vanilla, natural and artifical 33869 cotton candy, artificial 30-92-0011 glycerol high fructose corn syrup levomenthol peppermint oil povidone propylene glycol purified water saccharin sodium sodium chloride sodium citrate dihydrate - kaletra is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents in adults and children aged 2 years and older.

Israel - English - Ministry of Health

abbvie biopharmaceuticals ltd, israel - ritonavir - film coated tablets - ritonavir 100 mg - ritonavir - ritonavir - is indicated alone or in combination with other antiretroviral agents for the treatment of patients with hiv infection when therapy is warranted based on clinical and/or immunological evidence of disease progression

United States - English - NLM (National Library of Medicine)

abbvie inc. - ritonavir (unii: o3j8g9o825) (ritonavir - unii:o3j8g9o825), ombitasvir heminonahydrate (unii: eqe3i70j3w) (ombitasvir - unii:2302768xj8), paritaprevir dihydrate (unii: hrq5901o78) (paritaprevir - unii:ou2ym37k86) - ritonavir 50 mg - technivie is indicated in combination with ribavirin for the treatment of patients with genotype 4 chronic hepatitis c virus (hcv) infection without cirrhosis or with compensated cirrhosis [see clinical studies (14)] . - the contraindications to ribavirin also apply to this combination regimen. refer to the ribavirin prescribing information for a list of contraindications for ribavirin. - technivie is contraindicated: in patients with moderate to severe hepatic impairment (child-pugh b and c) due to risk of potential toxicity [see warnings and precautions (5.2), use in specific populations (8.6) and clinical pharmacology (12.3)] . with drugs that are highly dependent on cyp3a for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events [see drug interactions (7) and clinical pharmacology (12.3)] : alpha1-adrenoreceptor antagonist: alfuzosin hcl anti-anginal: ranolazine antiarrhythmic: dronedarone anti-gout: colchicine in patients with renal and/or hepat

United States - English - NLM (National Library of Medicine)

abbvie inc. - ritonavir (unii: o3j8g9o825) (ritonavir - unii:o3j8g9o825), dasabuvir sodium monohydrate (unii: og6d40m62l) (dasabuvir - unii:de54eqw8t1), paritaprevir dihydrate (unii: hrq5901o78) (paritaprevir - unii:ou2ym37k86), ombitasvir heminonahydrate (unii: eqe3i70j3w) (ombitasvir - unii:2302768xj8) - ritonavir 33.33 mg - viekira xr is indicated for the treatment of adult patients with chronic hepatitis c virus (hcv) [see dosage and administration (2.2) and clinical studies (14)] : - genotype 1b infection without cirrhosis or with compensated cirrhosis - genotype 1a infection without cirrhosis or with compensated cirrhosis for use in combination with ribavirin. - if viekira xr is administered with ribavirin, the contraindications to ribavirin also apply to this combination regimen. refer to the ribavirin prescribing information for a list of contraindications for ribavirin. - viekira xr is contraindicated: in patients with moderate to severe hepatic impairment (child-pugh b and c) due to risk of potential toxicity [see warnings and precautions (5.2), use in specific populations (8.6) and clinical pharmacology (12.3)] . with drugs that are highly dependent on cyp3a for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events [see drug interactions (7) and clinical pharmac

European Union - English - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - ritonavir - hiv infections - antivirals for systemic use, - ritonavir is indicated in combination with other antiretroviral agents for the treatment of hiv-1-infected patients (adults and children of two years of age and older).,

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - lopinavir 200 mg; ritonavir 50 mg - film-coated tablet - lopinavir and ritonavir

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - lopinavir 200 mg; ritonavir 50 mg - film-coated tablet - lopinavir and ritonavir

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - lopinavir 200 mg; ritonavir 50 mg - film-coated tablet - lopinavir and ritonavir